Fionnuala McAleese-Eser

Title: Fionnuala McAleese-Eser: Innovator in CD3 Binding Domains

Introduction

Fionnuala McAleese-Eser is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of CD3 binding domains. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Fionnuala holds a patent for her invention related to humanized CD3 binding sites. This invention comprises various combinations of variable heavy chain domains (VH) and variable light chain domains (VL), which have been designed to enhance stability while retaining binding affinity. The specific sequences outlined in her patent include SEQ ID NO:8, SEQ ID NO:3, SEQ ID NO:9, SEQ ID NO:4, SEQ ID NO:7, SEQ ID NO:2, SEQ ID NO:6, and SEQ ID NO:1. This innovative approach has the potential to improve therapeutic applications in immunology.

Career Highlights

Throughout her career, Fionnuala has worked with notable companies such as Affirmed GmbH and Affimed GmbH. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Fionnuala has collaborated with esteemed colleagues, including Eugene Zhukovsky and Melvyn Little. These partnerships have further enriched her work and expanded the impact of her inventions.

Conclusion

Fionnuala McAleese-Eser is a trailblazer in the field of biotechnology, with her innovative patent on CD3 binding domains showcasing her expertise. Her contributions to the industry are significant and continue to influence advancements in medical science.